Abstract
As man has used more and more chemical substances in his daily life, the subject of human toxicology has necessarily become increasingly important. One of the highest causes of human toxicity from chemical substances is the use of drugs whether for therapeutic or other purposes. Since the introduction of more stringent regulations for the registration of drugs it has become necessary to study the pharmacokinetics and pharmacology of new (and old) drugs in great detail. There is also a greater awareness of the possible toxic effects of the many substances in every day use — both domestic and industrial. Concern about our environment is widespread.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aherne, G. W. (1983). The specificity of morphine radioimmunoassays. Internal Congress and Symposium Series of The Royal Society of Medicine. No. 58, 21–9.
Aherne, G. W. (1984). Use and significance of immunoassay in the analysis of water. Analyt. Proc. 21, 177–9.
Aherne, G. W., Lawson, G. J., Quinton, M., and Marks, V. (1984). Drug determination in therapeutic and forensic contexts. In Reid, E. and Wilson, I. D. (eds.), Methodological Surveys in Biochemistry and Analysis Vol. 14, Plenum, London, 249–50.
Aherne, G. W., English, J., and Marks, V. (1984). The role of immunoassay in the analysis of micro-contaminants in water samples. Ecotox env. Safety 9, 79–83.
Aherne, G. W. (1982). The specificity of morphine radioimmunoassays. Intl. Cong. Symp. Ser. Roy. Soc. Med. 58, 21–9.
Aherne, G. W., and Marks, V. (1982). A radioimmunoassay for VP-16–213 in plasma. Cancer Chemother. Pharmacol. 7, 117–21.
Aherne, G. W., James, S. L., and Marks, V. (1981). The radioiodination of bleomycin using iodogen. Clin. Chim. Acta 119, 341–3.
Aherne, G. W., Piall, E. M., and Marks, V. (1976). The radioimmunoassay of tricyclic antidepressants. Br. J. Clin. Pharmacol. 3, 561–5.
Albano, J., and Ekins, R. P. (1970). In Proceedings of the Symposium on in vitro Procedures with Radioisotopes in Clinical Medicine and Research. International Atomic Energy Agency, Vienna, 491–512.
Bolton, A. E., and Hunter, W. H. (1973). The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Biochem. J. 133, 529–39.
Burke, C. W., and Shakespear, R. A. (1975). Rapid purification of triiodothyronine and thyroxine protein conjugates for antibody production. J. Endocr. 65, 133–8.
Butler, V. P., and Beiser, S. H. (1973). Antibodies to small molecules: biological and clinical applications. Adv. Immunol. 17, 255–310.
Collins, W. P., Barnard, G. J., Kim, J. B., Weerasekera, D. A., Kohen, F., Eshhar, Z., and Lindner, H. R. (1983). In Hunter, W. M. and Corrie, J. G. T. (eds.), Immunoassays for Clinical Chemistry, Churchill Livingstone, Edinburgh, 373–97.
Ekins, R. P. (1974). Basic principles and theory. Br. Med. Bull. 30, 3–11.
Ekins, R. (1981). In Voller, A., Bartlett, A., and Bidwell, D. (eds.), Immunoassays for the 80s, MTP Press, Lancaster, 5–17.
Ferrura, B., Milano, G., Ly, B., Guennec, J. Y., and Masseyeff, R. (1983). An enzyme immunoassay design using labelled antibodies for the determination of haptens: Application to methotrexate assay. J. Immunol. Methods 60, 257–69.
Findlay, J. W. A., Butz, R. F., and Jones, E. C. (1981). Relationships between immunogen structure and antisera specificity in the narcotic alkaloid series. Clin. Chem. 27, 1524–35.
Fraker, P. J., and Speck, J. C. (1978). Protein and cell membrane iodinations with a sparingly soluble chloroamide 1,3,4,6-tetrachloro-3α, 6α, diphenylglycouril. Biochem. Biophys. Res. Commun. 80, 849–57.
Grabinski, P. Y., Kaiko, R. F., Walsh, T. D., Foley, K. M., and Houde, R. W. (1983). Morphine radioimmunoassay specificity before and after extraction of plasma and cerebrospinal fluid. J. Pharm. Sci. 72, 27–30.
Greenwood, F C., Hunter, W. H., and Glover, J. S. (1963). The preparation of131I-labelled human growth hormone of high specific radioactivity. Biochem. J. 89, 114–23.
Harvey, M. H. (1983). The development and evaluation of a radioimmunoassay for the alkaloid solanidine in serum and the investigation of its levels in human serum. MSc Thesis, University of Surrey.
Hunter, W. H., and Greenwood, F. C. (1962). Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 194, 495–6.
Hurn, B. A. L. (1974). Practical problems in raising antisera. Br. Med. Bull. 30, 26–8.
Kamel, R. S., and Gardner, J. (1978). Preparation of125iodine-labelled methotrexate and its use in a magnetisable particle solid-phase radioimmunoassay. Clin. Chim. Acta 89, 363–70.
Landon, J., and Moffat, A. C. (1976). The radioimmunoassay of drugs. Analyst 101, 225–43.
Landsteiner, K. (1945). The Specificity of Serological Reactions, Harvard University Press, Boston. Reprinted by Dover, New York, 1962.
Levitt, Y. (1977). Radioimmunoassay for paraquat. Lancet II, 358.
Lindstrom, L., Meurling, L., and Lovgren, T. (1982). The measurement of serum cortisol by a solid-phase chemiluminescence immunoassay. J. Steroid. Biochem. 16, 577–80.
Lucek, R., and Dixon, R. (1977). Specific radioimmunoassay for amitriptyline and nortriptyline in plasma. Res. Commun. Chem. Pathol. Pharmacol. 18, 125–35.
Marks, V., Morris, B. A., and Teale, J. D. (1974). Pharmacology. Br. Med. Bull. 30, 80–6.
Mason, P. A., Law, B., and Ardney, R. E. (1981). Preparation of 2-iodomorphine for use in RIA. J. Lab. Comp. Radio-pharm. 18, 1497–507.
Mould, G. P., Stout, G., Aherne, G. W., and Marks, V. (1978). Radioimmunoassay of amitriptyline and nortriptyline in body fluids. Ann. Clin. Biochem. 15, 221–52.
Mould, G. P., Clough, J., Morris, B. A., Stout, G., and Marks, V. (1981). A propranalol radioimmunoassay and its use in the study of its pharmacokinetics following low doses. Biopharm. Drug Disp. 2, 49–57.
Nordblom, G. D., Webb, R., Counsell, R. E., and England, B. G. (1981). A chemical approach to solving bridging phenomena in steroid radioimmunoassays. Steroids 38, 161–73.
Okabayashi, T., Mihara, S., Repke, D. B., and Moffatt, J. G. (1977). A radioimmunoassay for 1-β-D-arabinofuranosyluracil with reference to cross-reactivity of 1-β-D-arabinofuranosylcytosine with an antibody. Cancer Research 37, 3132–5.
Oliver, G. C., Parker, B. H., Brasfield, D. L., and Parker, C. W. (1968). The measurement of digitoxin in human serum by radioimmunoassay. J. Clin. Invest. 47, 1035–42.
Piall, E. M., Aherne, G. W., and Marks, V. (1982). Evaluation of a commercially available radioimmunoassay kit for the measurement of doxorubin (adramycin) in plasma. Clin. Chem. 28, 119–21.
Ratcliffe, J. G., (1974). Separation techniques in saturation analysis. Br. Med. Bull. 30, 32–7.
Robinson, J. D., Morris, B. A., Piall, E. M., Aherne, G. W., and Marks, V. (1975). In Pasternak, C. A. (ed.), Radioimmunoassay in Clinical Biochemistry, Heyden, London, 101–13.
Robinson, J. D., Risby, D., Riley, G., and Aherne, G. W. (1978). A radioimmunoassay for the determination of combined amitriptyline and nortriptyline concentrations in microlitre samples of plasma. J. Pharmacol. Exp. Ther. 205, 499–502.
Salacinsky, P., Hope, J., and McLean, C. (1979). A new simple method which allows theoretical incorporation of radioiodine into proteins and peptides without damage. J. Endoc. 81, 131.
Sizaret, P., Malaveille, C., Montesano, R., and Frayssinet, C. (1982). Detection of aflotoxins and related metabolites by radioimmunoassay. J. Natl. Cancer Inst. 69, 1375–81.
Slevin, M. L., Piall, E. M., Aherne, G. W., Johnston, A., Sweatman, M. C., and Lister, T. A. (1981). The pharmacokinetics of subcutaneous cytosine arabinoside in patients with acute myelogenous leukaemia. Br. J. Clin. Pharmac. 12, 507–10.
Smith, T. W., Butler, V. P., Haber, E., Fozzard, H., Marcus, F., Bremner, F., Schulman, I. and Phillips, A. (1982). Treatment of life-threatening digitalis intoxication with digoxin specific fab antibody fragments. New Engl. J. Med. 307, 1357–62.
Smith, J., Pearson, S., and Marks, V. (1982). Plasma caffeine concentrations in outpatients. Lancet ii, 985–6.
Smith, R. N. (1983). Radioimmunoassay in forensic science. Analyt. Proc. 20, 417–19.
Soini, E., and Hemmila, I. (1979). Fluoroimmunoassay: Present status and key problems. Clin. Chem. 25, 353–61.
Stoller, R. G., Hande, K. R., Jacobs, S. A., and Chabner, B. A. (1977). Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity. New. Engl. J. Medicine 297, 630–4.
Teale, J. D., Clough, J. M., and Marks, V. (1977a). Radioimmunoassay of vinblastine and vincristine. Br. J. Clin. Pharmacol. 4, 160–72.
Teale, J. D., Clough, J. H., and Marks, V. (1977b). Radioimmunoassay of bleomycin in plasma and urine. Br. J. Cancer 33, 822–7.
Teale, J. D., Clough, J. M., King, L. J., Marks, V., Williams, P. L., and Moffat, A. C. (1977c). The incidence of cannabinoids in fatally injured drivers; an investigation by radioimmunoassay and high pressure liquid chromatography. J. Forens. Sci. Soc. 177–83.
Thorell, J. I., and Johansson, B. G. (1971). Enzymatic iodination of polypeptides with 125I to high specific activity. Biochim. Biophys. Acta 251, 363–9.
Tigelaar, R. E., Rapport, R. L., Inman, J. K., and Kupferberg, H. J. (1973). A radioimmunoassay for diphenylhydantoin. Clin. Chim. Acta 43, 231–41.
Vellejo, R. P., Bogus, E. R., and Mumma, R. O. (1982). Effects of hapten structure and bridging groups on antisera specificity in parathion immunoassay development. J. Agric. Food Chem. 30, 572–80.
Vining, R. F., Compton, P., and McGinley, R. (1981). Steroid radioimmunoassay — effect of shortened incubation time on specificity. Clin. Chem. 27, 910–13.
Voller, A., Bartlett, A., and Bidwell, D. E. (1978). Enzymeimmunoassays with special reference to ELISA techniques. J. Clin. Pathol. 31, 507–20.
Williams, P. L., Moffat, A. C., and King, L. J. (1978). Combined high-pressure liquid chromatography and radioimmunoassay method for the quantitation of delta-9-tetrahydrocannabinol and some of its metabolites in human plasma. J. Chromatogr. 155, 273–83.
Yalow, R. S., and Berson, S. A. (1960). Immunoassay of endogenous plasma insulin in man. J. Clin. Invest. 39, 1157–75.
Yalow, R. S., and Berson, S. A. (1970). In vitro Procedures with Radioisotopes in Clinical Medicine and Research. International Atomic Energy Agency, Vienna, 455–79.
Editor information
Copyright information
© 1986 The contributors
About this chapter
Cite this chapter
Aherne, G.W. (1986). Radioimmunoassays in Analytical Methods in Human Toxicology. In: Curry, A.S. (eds) Analytical Methods in Human Toxicology. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-07244-6_4
Download citation
DOI: https://doi.org/10.1007/978-1-349-07244-6_4
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-07246-0
Online ISBN: 978-1-349-07244-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)